These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 2167620)
21. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Kit S; Sheppard M; Ichimura H; Kit M Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972 [TBL] [Abstract][Full Text] [Related]
22. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres. Van Oirschot JT Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845 [TBL] [Abstract][Full Text] [Related]
23. Antibody response of pseudorabies virus subunit-vaccinated pigs to viral nucleocapsid proteins following low-dose virus challenge of immunity. McGinley MJ; Platt KB Am J Vet Res; 1989 Aug; 50(8):1290-3. PubMed ID: 2551199 [TBL] [Abstract][Full Text] [Related]
24. Genetic engineering of the pseudorabies virus genome to construct live vaccines. Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs. Mengeling WL; Brockmeier SL; Lager KM Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615 [TBL] [Abstract][Full Text] [Related]
26. Eradication of pseudorabies virus from three large swine herds achieved by management intervention and use of a vaccine with a deletion for glycoprotein I. Lehman JR; Weigel RM; Hall WF; Taft AC J Am Vet Med Assoc; 1994 Dec; 205(11):1581-7. PubMed ID: 7730129 [TBL] [Abstract][Full Text] [Related]
27. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine. Pensaert MB; Vandeputte J; Andries K Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610 [TBL] [Abstract][Full Text] [Related]
28. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665 [TBL] [Abstract][Full Text] [Related]
29. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs. McCaw MB; Xu J Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249 [TBL] [Abstract][Full Text] [Related]
30. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres. De Leeuw PW; Van Oirschot JT Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188 [TBL] [Abstract][Full Text] [Related]
31. Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs. Stegeman A; Van Nes A; de Jong MC; Bolder FW Am J Vet Res; 1995 May; 56(5):573-8. PubMed ID: 7661450 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077 [TBL] [Abstract][Full Text] [Related]
33. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs. Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244 [TBL] [Abstract][Full Text] [Related]
34. Effects of vaccination on lesion development in pseudorabies virus-challenged swine. Alva-Valdes R; Glock RD; Kluge JP; Keune CM Am J Vet Res; 1983 Apr; 44(4):588-95. PubMed ID: 6307084 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus. Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794 [TBL] [Abstract][Full Text] [Related]
36. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows. Andries K; Pensaert MB; Vandeputte J Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882 [TBL] [Abstract][Full Text] [Related]
37. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372 [TBL] [Abstract][Full Text] [Related]
38. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge. Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282 [TBL] [Abstract][Full Text] [Related]
39. Progress after one year of a pseudorabies eradication program for large swine herds. Lehman JR; Weigel RM; Siegel AM; Herr LG; Taft AC; Hall WF J Am Vet Med Assoc; 1993 Jul; 203(1):118-21. PubMed ID: 8407443 [TBL] [Abstract][Full Text] [Related]
40. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. McGregor S; Easterday BC; Kaplan AS; Ben-Porat T Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]